Global Bio-based Pentylenediamine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
It is an important C5 platform compound. It is a colorless smoky liquid with a smell similar to ammonia. It is easily soluble in water and ethanol.
LPI (LP Information)' newest research report, the “Bio-based Pentylenediamine Industry Forecast” looks at past sales and reviews total world Bio-based Pentylenediamine sales in 2022, providing a comprehensive analysis by region and market sector of projected Bio-based Pentylenediamine sales for 2023 through 2029. With Bio-based Pentylenediamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Pentylenediamine industry.
This Insight Report provides a comprehensive analysis of the global Bio-based Pentylenediamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Pentylenediamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bio-based Pentylenediamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Pentylenediamine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Pentylenediamine.
The global Bio-based Pentylenediamine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bio-based Pentylenediamine players cover Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Pentylenediamine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Bio-based Pentylenediamine market?
What factors are driving Bio-based Pentylenediamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-based Pentylenediamine market opportunities vary by end market size?
How does Bio-based Pentylenediamine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
It is an important C5 platform compound. It is a colorless smoky liquid with a smell similar to ammonia. It is easily soluble in water and ethanol.
LPI (LP Information)' newest research report, the “Bio-based Pentylenediamine Industry Forecast” looks at past sales and reviews total world Bio-based Pentylenediamine sales in 2022, providing a comprehensive analysis by region and market sector of projected Bio-based Pentylenediamine sales for 2023 through 2029. With Bio-based Pentylenediamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Pentylenediamine industry.
This Insight Report provides a comprehensive analysis of the global Bio-based Pentylenediamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Pentylenediamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bio-based Pentylenediamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Pentylenediamine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Pentylenediamine.
The global Bio-based Pentylenediamine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bio-based Pentylenediamine players cover Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Pentylenediamine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Polyamide
- PDI
- Epoxy Curing Agent
- Organic Synthesis Intermediate
- Others
- Spinning
- Engineering Materials
- Medicine
- Pesticides
- Organic Synthesis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cathay Biotech Inc.
- Aphena Pharma Solutions
- Bio-Tech Pharmacal
- Goodwin Biotechnology
- Xenon Pharmaceuticals
- Nektar Therapeutics
- Midas Pharmaceuticals
- Kedrion Biopharma
- Xcelthera
- Anichem
- ALC Bio Innovations
- ACADIA Pharmaceuticals
- AbbVie Inc.
- Ology Bioservices
- QMI - Quality Management
- Biomiga
- Molecular Targeting Technologies
What is the 10-year outlook for the global Bio-based Pentylenediamine market?
What factors are driving Bio-based Pentylenediamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-based Pentylenediamine market opportunities vary by end market size?
How does Bio-based Pentylenediamine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio-based Pentylenediamine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bio-based Pentylenediamine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bio-based Pentylenediamine by Country/Region, 2018, 2022 & 2029
2.2 Bio-based Pentylenediamine Segment by Type
2.2.1 Polyamide
2.2.2 PDI
2.2.3 Epoxy Curing Agent
2.2.4 Organic Synthesis Intermediate
2.2.5 Others
2.3 Bio-based Pentylenediamine Sales by Type
2.3.1 Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
2.3.2 Global Bio-based Pentylenediamine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bio-based Pentylenediamine Sale Price by Type (2018-2023)
2.4 Bio-based Pentylenediamine Segment by Application
2.4.1 Spinning
2.4.2 Engineering Materials
2.4.3 Medicine
2.4.4 Pesticides
2.4.5 Organic Synthesis
2.4.6 Others
2.5 Bio-based Pentylenediamine Sales by Application
2.5.1 Global Bio-based Pentylenediamine Sale Market Share by Application (2018-2023)
2.5.2 Global Bio-based Pentylenediamine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bio-based Pentylenediamine Sale Price by Application (2018-2023)
3 GLOBAL BIO-BASED PENTYLENEDIAMINE BY COMPANY
3.1 Global Bio-based Pentylenediamine Breakdown Data by Company
3.1.1 Global Bio-based Pentylenediamine Annual Sales by Company (2018-2023)
3.1.2 Global Bio-based Pentylenediamine Sales Market Share by Company (2018-2023)
3.2 Global Bio-based Pentylenediamine Annual Revenue by Company (2018-2023)
3.2.1 Global Bio-based Pentylenediamine Revenue by Company (2018-2023)
3.2.2 Global Bio-based Pentylenediamine Revenue Market Share by Company (2018-2023)
3.3 Global Bio-based Pentylenediamine Sale Price by Company
3.4 Key Manufacturers Bio-based Pentylenediamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-based Pentylenediamine Product Location Distribution
3.4.2 Players Bio-based Pentylenediamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIO-BASED PENTYLENEDIAMINE BY GEOGRAPHIC REGION
4.1 World Historic Bio-based Pentylenediamine Market Size by Geographic Region (2018-2023)
4.1.1 Global Bio-based Pentylenediamine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bio-based Pentylenediamine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bio-based Pentylenediamine Market Size by Country/Region (2018-2023)
4.2.1 Global Bio-based Pentylenediamine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bio-based Pentylenediamine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bio-based Pentylenediamine Sales Growth
4.4 APAC Bio-based Pentylenediamine Sales Growth
4.5 Europe Bio-based Pentylenediamine Sales Growth
4.6 Middle East & Africa Bio-based Pentylenediamine Sales Growth
5 AMERICAS
5.1 Americas Bio-based Pentylenediamine Sales by Country
5.1.1 Americas Bio-based Pentylenediamine Sales by Country (2018-2023)
5.1.2 Americas Bio-based Pentylenediamine Revenue by Country (2018-2023)
5.2 Americas Bio-based Pentylenediamine Sales by Type
5.3 Americas Bio-based Pentylenediamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-based Pentylenediamine Sales by Region
6.1.1 APAC Bio-based Pentylenediamine Sales by Region (2018-2023)
6.1.2 APAC Bio-based Pentylenediamine Revenue by Region (2018-2023)
6.2 APAC Bio-based Pentylenediamine Sales by Type
6.3 APAC Bio-based Pentylenediamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bio-based Pentylenediamine by Country
7.1.1 Europe Bio-based Pentylenediamine Sales by Country (2018-2023)
7.1.2 Europe Bio-based Pentylenediamine Revenue by Country (2018-2023)
7.2 Europe Bio-based Pentylenediamine Sales by Type
7.3 Europe Bio-based Pentylenediamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio-based Pentylenediamine by Country
8.1.1 Middle East & Africa Bio-based Pentylenediamine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bio-based Pentylenediamine Revenue by Country (2018-2023)
8.2 Middle East & Africa Bio-based Pentylenediamine Sales by Type
8.3 Middle East & Africa Bio-based Pentylenediamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-based Pentylenediamine
10.3 Manufacturing Process Analysis of Bio-based Pentylenediamine
10.4 Industry Chain Structure of Bio-based Pentylenediamine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-based Pentylenediamine Distributors
11.3 Bio-based Pentylenediamine Customer
12 WORLD FORECAST REVIEW FOR BIO-BASED PENTYLENEDIAMINE BY GEOGRAPHIC REGION
12.1 Global Bio-based Pentylenediamine Market Size Forecast by Region
12.1.1 Global Bio-based Pentylenediamine Forecast by Region (2024-2029)
12.1.2 Global Bio-based Pentylenediamine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bio-based Pentylenediamine Forecast by Type
12.7 Global Bio-based Pentylenediamine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Cathay Biotech Inc.
13.1.1 Cathay Biotech Inc. Company Information
13.1.2 Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
13.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cathay Biotech Inc. Main Business Overview
13.1.5 Cathay Biotech Inc. Latest Developments
13.2 Aphena Pharma Solutions
13.2.1 Aphena Pharma Solutions Company Information
13.2.2 Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolios and Specifications
13.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aphena Pharma Solutions Main Business Overview
13.2.5 Aphena Pharma Solutions Latest Developments
13.3 Bio-Tech Pharmacal
13.3.1 Bio-Tech Pharmacal Company Information
13.3.2 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolios and Specifications
13.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bio-Tech Pharmacal Main Business Overview
13.3.5 Bio-Tech Pharmacal Latest Developments
13.4 Goodwin Biotechnology
13.4.1 Goodwin Biotechnology Company Information
13.4.2 Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolios and Specifications
13.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Goodwin Biotechnology Main Business Overview
13.4.5 Goodwin Biotechnology Latest Developments
13.5 Xenon Pharmaceuticals
13.5.1 Xenon Pharmaceuticals Company Information
13.5.2 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
13.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Xenon Pharmaceuticals Main Business Overview
13.5.5 Xenon Pharmaceuticals Latest Developments
13.6 Nektar Therapeutics
13.6.1 Nektar Therapeutics Company Information
13.6.2 Nektar Therapeutics Bio-based Pentylenediamine Product Portfolios and Specifications
13.6.3 Nektar Therapeutics Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nektar Therapeutics Main Business Overview
13.6.5 Nektar Therapeutics Latest Developments
13.7 Midas Pharmaceuticals
13.7.1 Midas Pharmaceuticals Company Information
13.7.2 Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
13.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Midas Pharmaceuticals Main Business Overview
13.7.5 Midas Pharmaceuticals Latest Developments
13.8 Kedrion Biopharma
13.8.1 Kedrion Biopharma Company Information
13.8.2 Kedrion Biopharma Bio-based Pentylenediamine Product Portfolios and Specifications
13.8.3 Kedrion Biopharma Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Kedrion Biopharma Main Business Overview
13.8.5 Kedrion Biopharma Latest Developments
13.9 Xcelthera
13.9.1 Xcelthera Company Information
13.9.2 Xcelthera Bio-based Pentylenediamine Product Portfolios and Specifications
13.9.3 Xcelthera Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Xcelthera Main Business Overview
13.9.5 Xcelthera Latest Developments
13.10 Anichem
13.10.1 Anichem Company Information
13.10.2 Anichem Bio-based Pentylenediamine Product Portfolios and Specifications
13.10.3 Anichem Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Anichem Main Business Overview
13.10.5 Anichem Latest Developments
13.11 ALC Bio Innovations
13.11.1 ALC Bio Innovations Company Information
13.11.2 ALC Bio Innovations Bio-based Pentylenediamine Product Portfolios and Specifications
13.11.3 ALC Bio Innovations Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 ALC Bio Innovations Main Business Overview
13.11.5 ALC Bio Innovations Latest Developments
13.12 ACADIA Pharmaceuticals
13.12.1 ACADIA Pharmaceuticals Company Information
13.12.2 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
13.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ACADIA Pharmaceuticals Main Business Overview
13.12.5 ACADIA Pharmaceuticals Latest Developments
13.13 AbbVie Inc.
13.13.1 AbbVie Inc. Company Information
13.13.2 AbbVie Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
13.13.3 AbbVie Inc. Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Inc. Main Business Overview
13.13.5 AbbVie Inc. Latest Developments
13.14 Ology Bioservices
13.14.1 Ology Bioservices Company Information
13.14.2 Ology Bioservices Bio-based Pentylenediamine Product Portfolios and Specifications
13.14.3 Ology Bioservices Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ology Bioservices Main Business Overview
13.14.5 Ology Bioservices Latest Developments
13.15 QMI - Quality Management
13.15.1 QMI - Quality Management Company Information
13.15.2 QMI - Quality Management Bio-based Pentylenediamine Product Portfolios and Specifications
13.15.3 QMI - Quality Management Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 QMI - Quality Management Main Business Overview
13.15.5 QMI - Quality Management Latest Developments
13.16 Biomiga
13.16.1 Biomiga Company Information
13.16.2 Biomiga Bio-based Pentylenediamine Product Portfolios and Specifications
13.16.3 Biomiga Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Biomiga Main Business Overview
13.16.5 Biomiga Latest Developments
13.17 Molecular Targeting Technologies
13.17.1 Molecular Targeting Technologies Company Information
13.17.2 Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolios and Specifications
13.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Molecular Targeting Technologies Main Business Overview
13.17.5 Molecular Targeting Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio-based Pentylenediamine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bio-based Pentylenediamine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bio-based Pentylenediamine by Country/Region, 2018, 2022 & 2029
2.2 Bio-based Pentylenediamine Segment by Type
2.2.1 Polyamide
2.2.2 PDI
2.2.3 Epoxy Curing Agent
2.2.4 Organic Synthesis Intermediate
2.2.5 Others
2.3 Bio-based Pentylenediamine Sales by Type
2.3.1 Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
2.3.2 Global Bio-based Pentylenediamine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bio-based Pentylenediamine Sale Price by Type (2018-2023)
2.4 Bio-based Pentylenediamine Segment by Application
2.4.1 Spinning
2.4.2 Engineering Materials
2.4.3 Medicine
2.4.4 Pesticides
2.4.5 Organic Synthesis
2.4.6 Others
2.5 Bio-based Pentylenediamine Sales by Application
2.5.1 Global Bio-based Pentylenediamine Sale Market Share by Application (2018-2023)
2.5.2 Global Bio-based Pentylenediamine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bio-based Pentylenediamine Sale Price by Application (2018-2023)
3 GLOBAL BIO-BASED PENTYLENEDIAMINE BY COMPANY
3.1 Global Bio-based Pentylenediamine Breakdown Data by Company
3.1.1 Global Bio-based Pentylenediamine Annual Sales by Company (2018-2023)
3.1.2 Global Bio-based Pentylenediamine Sales Market Share by Company (2018-2023)
3.2 Global Bio-based Pentylenediamine Annual Revenue by Company (2018-2023)
3.2.1 Global Bio-based Pentylenediamine Revenue by Company (2018-2023)
3.2.2 Global Bio-based Pentylenediamine Revenue Market Share by Company (2018-2023)
3.3 Global Bio-based Pentylenediamine Sale Price by Company
3.4 Key Manufacturers Bio-based Pentylenediamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-based Pentylenediamine Product Location Distribution
3.4.2 Players Bio-based Pentylenediamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIO-BASED PENTYLENEDIAMINE BY GEOGRAPHIC REGION
4.1 World Historic Bio-based Pentylenediamine Market Size by Geographic Region (2018-2023)
4.1.1 Global Bio-based Pentylenediamine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bio-based Pentylenediamine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bio-based Pentylenediamine Market Size by Country/Region (2018-2023)
4.2.1 Global Bio-based Pentylenediamine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bio-based Pentylenediamine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bio-based Pentylenediamine Sales Growth
4.4 APAC Bio-based Pentylenediamine Sales Growth
4.5 Europe Bio-based Pentylenediamine Sales Growth
4.6 Middle East & Africa Bio-based Pentylenediamine Sales Growth
5 AMERICAS
5.1 Americas Bio-based Pentylenediamine Sales by Country
5.1.1 Americas Bio-based Pentylenediamine Sales by Country (2018-2023)
5.1.2 Americas Bio-based Pentylenediamine Revenue by Country (2018-2023)
5.2 Americas Bio-based Pentylenediamine Sales by Type
5.3 Americas Bio-based Pentylenediamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-based Pentylenediamine Sales by Region
6.1.1 APAC Bio-based Pentylenediamine Sales by Region (2018-2023)
6.1.2 APAC Bio-based Pentylenediamine Revenue by Region (2018-2023)
6.2 APAC Bio-based Pentylenediamine Sales by Type
6.3 APAC Bio-based Pentylenediamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bio-based Pentylenediamine by Country
7.1.1 Europe Bio-based Pentylenediamine Sales by Country (2018-2023)
7.1.2 Europe Bio-based Pentylenediamine Revenue by Country (2018-2023)
7.2 Europe Bio-based Pentylenediamine Sales by Type
7.3 Europe Bio-based Pentylenediamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio-based Pentylenediamine by Country
8.1.1 Middle East & Africa Bio-based Pentylenediamine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bio-based Pentylenediamine Revenue by Country (2018-2023)
8.2 Middle East & Africa Bio-based Pentylenediamine Sales by Type
8.3 Middle East & Africa Bio-based Pentylenediamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-based Pentylenediamine
10.3 Manufacturing Process Analysis of Bio-based Pentylenediamine
10.4 Industry Chain Structure of Bio-based Pentylenediamine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-based Pentylenediamine Distributors
11.3 Bio-based Pentylenediamine Customer
12 WORLD FORECAST REVIEW FOR BIO-BASED PENTYLENEDIAMINE BY GEOGRAPHIC REGION
12.1 Global Bio-based Pentylenediamine Market Size Forecast by Region
12.1.1 Global Bio-based Pentylenediamine Forecast by Region (2024-2029)
12.1.2 Global Bio-based Pentylenediamine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bio-based Pentylenediamine Forecast by Type
12.7 Global Bio-based Pentylenediamine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Cathay Biotech Inc.
13.1.1 Cathay Biotech Inc. Company Information
13.1.2 Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
13.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cathay Biotech Inc. Main Business Overview
13.1.5 Cathay Biotech Inc. Latest Developments
13.2 Aphena Pharma Solutions
13.2.1 Aphena Pharma Solutions Company Information
13.2.2 Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolios and Specifications
13.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aphena Pharma Solutions Main Business Overview
13.2.5 Aphena Pharma Solutions Latest Developments
13.3 Bio-Tech Pharmacal
13.3.1 Bio-Tech Pharmacal Company Information
13.3.2 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolios and Specifications
13.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bio-Tech Pharmacal Main Business Overview
13.3.5 Bio-Tech Pharmacal Latest Developments
13.4 Goodwin Biotechnology
13.4.1 Goodwin Biotechnology Company Information
13.4.2 Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolios and Specifications
13.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Goodwin Biotechnology Main Business Overview
13.4.5 Goodwin Biotechnology Latest Developments
13.5 Xenon Pharmaceuticals
13.5.1 Xenon Pharmaceuticals Company Information
13.5.2 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
13.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Xenon Pharmaceuticals Main Business Overview
13.5.5 Xenon Pharmaceuticals Latest Developments
13.6 Nektar Therapeutics
13.6.1 Nektar Therapeutics Company Information
13.6.2 Nektar Therapeutics Bio-based Pentylenediamine Product Portfolios and Specifications
13.6.3 Nektar Therapeutics Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nektar Therapeutics Main Business Overview
13.6.5 Nektar Therapeutics Latest Developments
13.7 Midas Pharmaceuticals
13.7.1 Midas Pharmaceuticals Company Information
13.7.2 Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
13.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Midas Pharmaceuticals Main Business Overview
13.7.5 Midas Pharmaceuticals Latest Developments
13.8 Kedrion Biopharma
13.8.1 Kedrion Biopharma Company Information
13.8.2 Kedrion Biopharma Bio-based Pentylenediamine Product Portfolios and Specifications
13.8.3 Kedrion Biopharma Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Kedrion Biopharma Main Business Overview
13.8.5 Kedrion Biopharma Latest Developments
13.9 Xcelthera
13.9.1 Xcelthera Company Information
13.9.2 Xcelthera Bio-based Pentylenediamine Product Portfolios and Specifications
13.9.3 Xcelthera Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Xcelthera Main Business Overview
13.9.5 Xcelthera Latest Developments
13.10 Anichem
13.10.1 Anichem Company Information
13.10.2 Anichem Bio-based Pentylenediamine Product Portfolios and Specifications
13.10.3 Anichem Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Anichem Main Business Overview
13.10.5 Anichem Latest Developments
13.11 ALC Bio Innovations
13.11.1 ALC Bio Innovations Company Information
13.11.2 ALC Bio Innovations Bio-based Pentylenediamine Product Portfolios and Specifications
13.11.3 ALC Bio Innovations Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 ALC Bio Innovations Main Business Overview
13.11.5 ALC Bio Innovations Latest Developments
13.12 ACADIA Pharmaceuticals
13.12.1 ACADIA Pharmaceuticals Company Information
13.12.2 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
13.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ACADIA Pharmaceuticals Main Business Overview
13.12.5 ACADIA Pharmaceuticals Latest Developments
13.13 AbbVie Inc.
13.13.1 AbbVie Inc. Company Information
13.13.2 AbbVie Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
13.13.3 AbbVie Inc. Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Inc. Main Business Overview
13.13.5 AbbVie Inc. Latest Developments
13.14 Ology Bioservices
13.14.1 Ology Bioservices Company Information
13.14.2 Ology Bioservices Bio-based Pentylenediamine Product Portfolios and Specifications
13.14.3 Ology Bioservices Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ology Bioservices Main Business Overview
13.14.5 Ology Bioservices Latest Developments
13.15 QMI - Quality Management
13.15.1 QMI - Quality Management Company Information
13.15.2 QMI - Quality Management Bio-based Pentylenediamine Product Portfolios and Specifications
13.15.3 QMI - Quality Management Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 QMI - Quality Management Main Business Overview
13.15.5 QMI - Quality Management Latest Developments
13.16 Biomiga
13.16.1 Biomiga Company Information
13.16.2 Biomiga Bio-based Pentylenediamine Product Portfolios and Specifications
13.16.3 Biomiga Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Biomiga Main Business Overview
13.16.5 Biomiga Latest Developments
13.17 Molecular Targeting Technologies
13.17.1 Molecular Targeting Technologies Company Information
13.17.2 Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolios and Specifications
13.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Molecular Targeting Technologies Main Business Overview
13.17.5 Molecular Targeting Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bio-based Pentylenediamine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bio-based Pentylenediamine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Polyamide
Table 4. Major Players of PDI
Table 5. Major Players of Epoxy Curing Agent
Table 6. Major Players of Organic Synthesis Intermediate
Table 7. Major Players of Others
Table 8. Global Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 9. Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Table 10. Global Bio-based Pentylenediamine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2023)
Table 12. Global Bio-based Pentylenediamine Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 14. Global Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Table 15. Global Bio-based Pentylenediamine Revenue by Application (2018-2023)
Table 16. Global Bio-based Pentylenediamine Revenue Market Share by Application (2018-2023)
Table 17. Global Bio-based Pentylenediamine Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Bio-based Pentylenediamine Sales by Company (2018-2023) & (Tons)
Table 19. Global Bio-based Pentylenediamine Sales Market Share by Company (2018-2023)
Table 20. Global Bio-based Pentylenediamine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Bio-based Pentylenediamine Revenue Market Share by Company (2018-2023)
Table 22. Global Bio-based Pentylenediamine Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Bio-based Pentylenediamine Producing Area Distribution and Sales Area
Table 24. Players Bio-based Pentylenediamine Products Offered
Table 25. Bio-based Pentylenediamine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Bio-based Pentylenediamine Sales by Geographic Region (2018-2023) & (Tons)
Table 29. Global Bio-based Pentylenediamine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Bio-based Pentylenediamine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Bio-based Pentylenediamine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Bio-based Pentylenediamine Sales by Country/Region (2018-2023) & (Tons)
Table 33. Global Bio-based Pentylenediamine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Bio-based Pentylenediamine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Bio-based Pentylenediamine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 37. Americas Bio-based Pentylenediamine Sales Market Share by Country (2018-2023)
Table 38. Americas Bio-based Pentylenediamine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Bio-based Pentylenediamine Revenue Market Share by Country (2018-2023)
Table 40. Americas Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 41. Americas Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 42. APAC Bio-based Pentylenediamine Sales by Region (2018-2023) & (Tons)
Table 43. APAC Bio-based Pentylenediamine Sales Market Share by Region (2018-2023)
Table 44. APAC Bio-based Pentylenediamine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Bio-based Pentylenediamine Revenue Market Share by Region (2018-2023)
Table 46. APAC Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 47. APAC Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 48. Europe Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 49. Europe Bio-based Pentylenediamine Sales Market Share by Country (2018-2023)
Table 50. Europe Bio-based Pentylenediamine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Bio-based Pentylenediamine Revenue Market Share by Country (2018-2023)
Table 52. Europe Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 53. Europe Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 54. Middle East & Africa Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 55. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Bio-based Pentylenediamine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Bio-based Pentylenediamine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 59. Middle East & Africa Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Bio-based Pentylenediamine
Table 61. Key Market Challenges & Risks of Bio-based Pentylenediamine
Table 62. Key Industry Trends of Bio-based Pentylenediamine
Table 63. Bio-based Pentylenediamine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Bio-based Pentylenediamine Distributors List
Table 66. Bio-based Pentylenediamine Customer List
Table 67. Global Bio-based Pentylenediamine Sales Forecast by Region (2024-2029) & (Tons)
Table 68. Global Bio-based Pentylenediamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Bio-based Pentylenediamine Sales Forecast by Country (2024-2029) & (Tons)
Table 70. Americas Bio-based Pentylenediamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Bio-based Pentylenediamine Sales Forecast by Region (2024-2029) & (Tons)
Table 72. APAC Bio-based Pentylenediamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Bio-based Pentylenediamine Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Europe Bio-based Pentylenediamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Bio-based Pentylenediamine Sales Forecast by Country (2024-2029) & (Tons)
Table 76. Middle East & Africa Bio-based Pentylenediamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Bio-based Pentylenediamine Sales Forecast by Type (2024-2029) & (Tons)
Table 78. Global Bio-based Pentylenediamine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Bio-based Pentylenediamine Sales Forecast by Application (2024-2029) & (Tons)
Table 80. Global Bio-based Pentylenediamine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Cathay Biotech Inc. Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 82. Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
Table 83. Cathay Biotech Inc. Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. Cathay Biotech Inc. Main Business
Table 85. Cathay Biotech Inc. Latest Developments
Table 86. Aphena Pharma Solutions Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 87. Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolios and Specifications
Table 88. Aphena Pharma Solutions Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Aphena Pharma Solutions Main Business
Table 90. Aphena Pharma Solutions Latest Developments
Table 91. Bio-Tech Pharmacal Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 92. Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolios and Specifications
Table 93. Bio-Tech Pharmacal Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Bio-Tech Pharmacal Main Business
Table 95. Bio-Tech Pharmacal Latest Developments
Table 96. Goodwin Biotechnology Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 97. Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolios and Specifications
Table 98. Goodwin Biotechnology Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Goodwin Biotechnology Main Business
Table 100. Goodwin Biotechnology Latest Developments
Table 101. Xenon Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 102. Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 103. Xenon Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. Xenon Pharmaceuticals Main Business
Table 105. Xenon Pharmaceuticals Latest Developments
Table 106. Nektar Therapeutics Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 107. Nektar Therapeutics Bio-based Pentylenediamine Product Portfolios and Specifications
Table 108. Nektar Therapeutics Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Nektar Therapeutics Main Business
Table 110. Nektar Therapeutics Latest Developments
Table 111. Midas Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 112. Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 113. Midas Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Midas Pharmaceuticals Main Business
Table 115. Midas Pharmaceuticals Latest Developments
Table 116. Kedrion Biopharma Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 117. Kedrion Biopharma Bio-based Pentylenediamine Product Portfolios and Specifications
Table 118. Kedrion Biopharma Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Kedrion Biopharma Main Business
Table 120. Kedrion Biopharma Latest Developments
Table 121. Xcelthera Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 122. Xcelthera Bio-based Pentylenediamine Product Portfolios and Specifications
Table 123. Xcelthera Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Xcelthera Main Business
Table 125. Xcelthera Latest Developments
Table 126. Anichem Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 127. Anichem Bio-based Pentylenediamine Product Portfolios and Specifications
Table 128. Anichem Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Anichem Main Business
Table 130. Anichem Latest Developments
Table 131. ALC Bio Innovations Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 132. ALC Bio Innovations Bio-based Pentylenediamine Product Portfolios and Specifications
Table 133. ALC Bio Innovations Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. ALC Bio Innovations Main Business
Table 135. ALC Bio Innovations Latest Developments
Table 136. ACADIA Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 137. ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 138. ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. ACADIA Pharmaceuticals Main Business
Table 140. ACADIA Pharmaceuticals Latest Developments
Table 141. AbbVie Inc. Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 142. AbbVie Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
Table 143. AbbVie Inc. Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 144. AbbVie Inc. Main Business
Table 145. AbbVie Inc. Latest Developments
Table 146. Ology Bioservices Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 147. Ology Bioservices Bio-based Pentylenediamine Product Portfolios and Specifications
Table 148. Ology Bioservices Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 149. Ology Bioservices Main Business
Table 150. Ology Bioservices Latest Developments
Table 151. QMI - Quality Management Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 152. QMI - Quality Management Bio-based Pentylenediamine Product Portfolios and Specifications
Table 153. QMI - Quality Management Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 154. QMI - Quality Management Main Business
Table 155. QMI - Quality Management Latest Developments
Table 156. Biomiga Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 157. Biomiga Bio-based Pentylenediamine Product Portfolios and Specifications
Table 158. Biomiga Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 159. Biomiga Main Business
Table 160. Biomiga Latest Developments
Table 161. Molecular Targeting Technologies Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 162. Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolios and Specifications
Table 163. Molecular Targeting Technologies Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 164. Molecular Targeting Technologies Main Business
Table 165. Molecular Targeting Technologies Latest Developments
Table 1. Bio-based Pentylenediamine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bio-based Pentylenediamine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Polyamide
Table 4. Major Players of PDI
Table 5. Major Players of Epoxy Curing Agent
Table 6. Major Players of Organic Synthesis Intermediate
Table 7. Major Players of Others
Table 8. Global Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 9. Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Table 10. Global Bio-based Pentylenediamine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2023)
Table 12. Global Bio-based Pentylenediamine Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 14. Global Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Table 15. Global Bio-based Pentylenediamine Revenue by Application (2018-2023)
Table 16. Global Bio-based Pentylenediamine Revenue Market Share by Application (2018-2023)
Table 17. Global Bio-based Pentylenediamine Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Bio-based Pentylenediamine Sales by Company (2018-2023) & (Tons)
Table 19. Global Bio-based Pentylenediamine Sales Market Share by Company (2018-2023)
Table 20. Global Bio-based Pentylenediamine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Bio-based Pentylenediamine Revenue Market Share by Company (2018-2023)
Table 22. Global Bio-based Pentylenediamine Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Bio-based Pentylenediamine Producing Area Distribution and Sales Area
Table 24. Players Bio-based Pentylenediamine Products Offered
Table 25. Bio-based Pentylenediamine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Bio-based Pentylenediamine Sales by Geographic Region (2018-2023) & (Tons)
Table 29. Global Bio-based Pentylenediamine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Bio-based Pentylenediamine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Bio-based Pentylenediamine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Bio-based Pentylenediamine Sales by Country/Region (2018-2023) & (Tons)
Table 33. Global Bio-based Pentylenediamine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Bio-based Pentylenediamine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Bio-based Pentylenediamine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 37. Americas Bio-based Pentylenediamine Sales Market Share by Country (2018-2023)
Table 38. Americas Bio-based Pentylenediamine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Bio-based Pentylenediamine Revenue Market Share by Country (2018-2023)
Table 40. Americas Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 41. Americas Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 42. APAC Bio-based Pentylenediamine Sales by Region (2018-2023) & (Tons)
Table 43. APAC Bio-based Pentylenediamine Sales Market Share by Region (2018-2023)
Table 44. APAC Bio-based Pentylenediamine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Bio-based Pentylenediamine Revenue Market Share by Region (2018-2023)
Table 46. APAC Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 47. APAC Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 48. Europe Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 49. Europe Bio-based Pentylenediamine Sales Market Share by Country (2018-2023)
Table 50. Europe Bio-based Pentylenediamine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Bio-based Pentylenediamine Revenue Market Share by Country (2018-2023)
Table 52. Europe Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 53. Europe Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 54. Middle East & Africa Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 55. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Bio-based Pentylenediamine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Bio-based Pentylenediamine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 59. Middle East & Africa Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Bio-based Pentylenediamine
Table 61. Key Market Challenges & Risks of Bio-based Pentylenediamine
Table 62. Key Industry Trends of Bio-based Pentylenediamine
Table 63. Bio-based Pentylenediamine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Bio-based Pentylenediamine Distributors List
Table 66. Bio-based Pentylenediamine Customer List
Table 67. Global Bio-based Pentylenediamine Sales Forecast by Region (2024-2029) & (Tons)
Table 68. Global Bio-based Pentylenediamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Bio-based Pentylenediamine Sales Forecast by Country (2024-2029) & (Tons)
Table 70. Americas Bio-based Pentylenediamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Bio-based Pentylenediamine Sales Forecast by Region (2024-2029) & (Tons)
Table 72. APAC Bio-based Pentylenediamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Bio-based Pentylenediamine Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Europe Bio-based Pentylenediamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Bio-based Pentylenediamine Sales Forecast by Country (2024-2029) & (Tons)
Table 76. Middle East & Africa Bio-based Pentylenediamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Bio-based Pentylenediamine Sales Forecast by Type (2024-2029) & (Tons)
Table 78. Global Bio-based Pentylenediamine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Bio-based Pentylenediamine Sales Forecast by Application (2024-2029) & (Tons)
Table 80. Global Bio-based Pentylenediamine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Cathay Biotech Inc. Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 82. Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
Table 83. Cathay Biotech Inc. Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. Cathay Biotech Inc. Main Business
Table 85. Cathay Biotech Inc. Latest Developments
Table 86. Aphena Pharma Solutions Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 87. Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolios and Specifications
Table 88. Aphena Pharma Solutions Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Aphena Pharma Solutions Main Business
Table 90. Aphena Pharma Solutions Latest Developments
Table 91. Bio-Tech Pharmacal Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 92. Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolios and Specifications
Table 93. Bio-Tech Pharmacal Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Bio-Tech Pharmacal Main Business
Table 95. Bio-Tech Pharmacal Latest Developments
Table 96. Goodwin Biotechnology Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 97. Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolios and Specifications
Table 98. Goodwin Biotechnology Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Goodwin Biotechnology Main Business
Table 100. Goodwin Biotechnology Latest Developments
Table 101. Xenon Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 102. Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 103. Xenon Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. Xenon Pharmaceuticals Main Business
Table 105. Xenon Pharmaceuticals Latest Developments
Table 106. Nektar Therapeutics Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 107. Nektar Therapeutics Bio-based Pentylenediamine Product Portfolios and Specifications
Table 108. Nektar Therapeutics Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Nektar Therapeutics Main Business
Table 110. Nektar Therapeutics Latest Developments
Table 111. Midas Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 112. Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 113. Midas Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Midas Pharmaceuticals Main Business
Table 115. Midas Pharmaceuticals Latest Developments
Table 116. Kedrion Biopharma Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 117. Kedrion Biopharma Bio-based Pentylenediamine Product Portfolios and Specifications
Table 118. Kedrion Biopharma Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Kedrion Biopharma Main Business
Table 120. Kedrion Biopharma Latest Developments
Table 121. Xcelthera Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 122. Xcelthera Bio-based Pentylenediamine Product Portfolios and Specifications
Table 123. Xcelthera Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Xcelthera Main Business
Table 125. Xcelthera Latest Developments
Table 126. Anichem Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 127. Anichem Bio-based Pentylenediamine Product Portfolios and Specifications
Table 128. Anichem Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Anichem Main Business
Table 130. Anichem Latest Developments
Table 131. ALC Bio Innovations Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 132. ALC Bio Innovations Bio-based Pentylenediamine Product Portfolios and Specifications
Table 133. ALC Bio Innovations Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. ALC Bio Innovations Main Business
Table 135. ALC Bio Innovations Latest Developments
Table 136. ACADIA Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 137. ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 138. ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. ACADIA Pharmaceuticals Main Business
Table 140. ACADIA Pharmaceuticals Latest Developments
Table 141. AbbVie Inc. Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 142. AbbVie Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
Table 143. AbbVie Inc. Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 144. AbbVie Inc. Main Business
Table 145. AbbVie Inc. Latest Developments
Table 146. Ology Bioservices Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 147. Ology Bioservices Bio-based Pentylenediamine Product Portfolios and Specifications
Table 148. Ology Bioservices Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 149. Ology Bioservices Main Business
Table 150. Ology Bioservices Latest Developments
Table 151. QMI - Quality Management Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 152. QMI - Quality Management Bio-based Pentylenediamine Product Portfolios and Specifications
Table 153. QMI - Quality Management Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 154. QMI - Quality Management Main Business
Table 155. QMI - Quality Management Latest Developments
Table 156. Biomiga Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 157. Biomiga Bio-based Pentylenediamine Product Portfolios and Specifications
Table 158. Biomiga Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 159. Biomiga Main Business
Table 160. Biomiga Latest Developments
Table 161. Molecular Targeting Technologies Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 162. Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolios and Specifications
Table 163. Molecular Targeting Technologies Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 164. Molecular Targeting Technologies Main Business
Table 165. Molecular Targeting Technologies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Bio-based Pentylenediamine
Figure 2. Bio-based Pentylenediamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-based Pentylenediamine Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Bio-based Pentylenediamine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bio-based Pentylenediamine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Polyamide
Figure 10. Product Picture of PDI
Figure 11. Product Picture of Epoxy Curing Agent
Figure 12. Product Picture of Organic Synthesis Intermediate
Figure 13. Product Picture of Others
Figure 14. Global Bio-based Pentylenediamine Sales Market Share by Type in 2022
Figure 15. Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2023)
Figure 16. Bio-based Pentylenediamine Consumed in Spinning
Figure 17. Global Bio-based Pentylenediamine Market: Spinning (2018-2023) & (Tons)
Figure 18. Bio-based Pentylenediamine Consumed in Engineering Materials
Figure 19. Global Bio-based Pentylenediamine Market: Engineering Materials (2018-2023) & (Tons)
Figure 20. Bio-based Pentylenediamine Consumed in Medicine
Figure 21. Global Bio-based Pentylenediamine Market: Medicine (2018-2023) & (Tons)
Figure 22. Bio-based Pentylenediamine Consumed in Pesticides
Figure 23. Global Bio-based Pentylenediamine Market: Pesticides (2018-2023) & (Tons)
Figure 24. Bio-based Pentylenediamine Consumed in Organic Synthesis
Figure 25. Global Bio-based Pentylenediamine Market: Organic Synthesis (2018-2023) & (Tons)
Figure 26. Bio-based Pentylenediamine Consumed in Others
Figure 27. Global Bio-based Pentylenediamine Market: Others (2018-2023) & (Tons)
Figure 28. Global Bio-based Pentylenediamine Sales Market Share by Application (2022)
Figure 29. Global Bio-based Pentylenediamine Revenue Market Share by Application in 2022
Figure 30. Bio-based Pentylenediamine Sales Market by Company in 2022 (Tons)
Figure 31. Global Bio-based Pentylenediamine Sales Market Share by Company in 2022
Figure 32. Bio-based Pentylenediamine Revenue Market by Company in 2022 ($ Million)
Figure 33. Global Bio-based Pentylenediamine Revenue Market Share by Company in 2022
Figure 34. Global Bio-based Pentylenediamine Sales Market Share by Geographic Region (2018-2023)
Figure 35. Global Bio-based Pentylenediamine Revenue Market Share by Geographic Region in 2022
Figure 36. Americas Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 37. Americas Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 38. APAC Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 39. APAC Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 40. Europe Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 41. Europe Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 42. Middle East & Africa Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 43. Middle East & Africa Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 44. Americas Bio-based Pentylenediamine Sales Market Share by Country in 2022
Figure 45. Americas Bio-based Pentylenediamine Revenue Market Share by Country in 2022
Figure 46. Americas Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 47. Americas Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 48. United States Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Canada Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Mexico Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Brazil Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 52. APAC Bio-based Pentylenediamine Sales Market Share by Region in 2022
Figure 53. APAC Bio-based Pentylenediamine Revenue Market Share by Regions in 2022
Figure 54. APAC Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 55. APAC Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 56. China Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Japan Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 58. South Korea Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Southeast Asia Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 60. India Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Australia Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 62. China Taiwan Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Europe Bio-based Pentylenediamine Sales Market Share by Country in 2022
Figure 64. Europe Bio-based Pentylenediamine Revenue Market Share by Country in 2022
Figure 65. Europe Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 66. Europe Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 67. Germany Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 68. France Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 69. UK Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Italy Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Russia Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Country in 2022
Figure 73. Middle East & Africa Bio-based Pentylenediamine Revenue Market Share by Country in 2022
Figure 74. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 75. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 76. Egypt Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 77. South Africa Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 78. Israel Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 79. Turkey Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 80. GCC Country Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Bio-based Pentylenediamine in 2022
Figure 82. Manufacturing Process Analysis of Bio-based Pentylenediamine
Figure 83. Industry Chain Structure of Bio-based Pentylenediamine
Figure 84. Channels of Distribution
Figure 85. Global Bio-based Pentylenediamine Sales Market Forecast by Region (2024-2029)
Figure 86. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Region (2024-2029)
Figure 87. Global Bio-based Pentylenediamine Sales Market Share Forecast by Type (2024-2029)
Figure 88. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Type (2024-2029)
Figure 89. Global Bio-based Pentylenediamine Sales Market Share Forecast by Application (2024-2029)
Figure 90. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Bio-based Pentylenediamine
Figure 2. Bio-based Pentylenediamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-based Pentylenediamine Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Bio-based Pentylenediamine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bio-based Pentylenediamine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Polyamide
Figure 10. Product Picture of PDI
Figure 11. Product Picture of Epoxy Curing Agent
Figure 12. Product Picture of Organic Synthesis Intermediate
Figure 13. Product Picture of Others
Figure 14. Global Bio-based Pentylenediamine Sales Market Share by Type in 2022
Figure 15. Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2023)
Figure 16. Bio-based Pentylenediamine Consumed in Spinning
Figure 17. Global Bio-based Pentylenediamine Market: Spinning (2018-2023) & (Tons)
Figure 18. Bio-based Pentylenediamine Consumed in Engineering Materials
Figure 19. Global Bio-based Pentylenediamine Market: Engineering Materials (2018-2023) & (Tons)
Figure 20. Bio-based Pentylenediamine Consumed in Medicine
Figure 21. Global Bio-based Pentylenediamine Market: Medicine (2018-2023) & (Tons)
Figure 22. Bio-based Pentylenediamine Consumed in Pesticides
Figure 23. Global Bio-based Pentylenediamine Market: Pesticides (2018-2023) & (Tons)
Figure 24. Bio-based Pentylenediamine Consumed in Organic Synthesis
Figure 25. Global Bio-based Pentylenediamine Market: Organic Synthesis (2018-2023) & (Tons)
Figure 26. Bio-based Pentylenediamine Consumed in Others
Figure 27. Global Bio-based Pentylenediamine Market: Others (2018-2023) & (Tons)
Figure 28. Global Bio-based Pentylenediamine Sales Market Share by Application (2022)
Figure 29. Global Bio-based Pentylenediamine Revenue Market Share by Application in 2022
Figure 30. Bio-based Pentylenediamine Sales Market by Company in 2022 (Tons)
Figure 31. Global Bio-based Pentylenediamine Sales Market Share by Company in 2022
Figure 32. Bio-based Pentylenediamine Revenue Market by Company in 2022 ($ Million)
Figure 33. Global Bio-based Pentylenediamine Revenue Market Share by Company in 2022
Figure 34. Global Bio-based Pentylenediamine Sales Market Share by Geographic Region (2018-2023)
Figure 35. Global Bio-based Pentylenediamine Revenue Market Share by Geographic Region in 2022
Figure 36. Americas Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 37. Americas Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 38. APAC Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 39. APAC Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 40. Europe Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 41. Europe Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 42. Middle East & Africa Bio-based Pentylenediamine Sales 2018-2023 (Tons)
Figure 43. Middle East & Africa Bio-based Pentylenediamine Revenue 2018-2023 ($ Millions)
Figure 44. Americas Bio-based Pentylenediamine Sales Market Share by Country in 2022
Figure 45. Americas Bio-based Pentylenediamine Revenue Market Share by Country in 2022
Figure 46. Americas Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 47. Americas Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 48. United States Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Canada Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Mexico Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Brazil Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 52. APAC Bio-based Pentylenediamine Sales Market Share by Region in 2022
Figure 53. APAC Bio-based Pentylenediamine Revenue Market Share by Regions in 2022
Figure 54. APAC Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 55. APAC Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 56. China Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Japan Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 58. South Korea Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Southeast Asia Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 60. India Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Australia Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 62. China Taiwan Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Europe Bio-based Pentylenediamine Sales Market Share by Country in 2022
Figure 64. Europe Bio-based Pentylenediamine Revenue Market Share by Country in 2022
Figure 65. Europe Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 66. Europe Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 67. Germany Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 68. France Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 69. UK Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Italy Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Russia Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Country in 2022
Figure 73. Middle East & Africa Bio-based Pentylenediamine Revenue Market Share by Country in 2022
Figure 74. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Type (2018-2023)
Figure 75. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Application (2018-2023)
Figure 76. Egypt Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 77. South Africa Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 78. Israel Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 79. Turkey Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 80. GCC Country Bio-based Pentylenediamine Revenue Growth 2018-2023 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Bio-based Pentylenediamine in 2022
Figure 82. Manufacturing Process Analysis of Bio-based Pentylenediamine
Figure 83. Industry Chain Structure of Bio-based Pentylenediamine
Figure 84. Channels of Distribution
Figure 85. Global Bio-based Pentylenediamine Sales Market Forecast by Region (2024-2029)
Figure 86. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Region (2024-2029)
Figure 87. Global Bio-based Pentylenediamine Sales Market Share Forecast by Type (2024-2029)
Figure 88. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Type (2024-2029)
Figure 89. Global Bio-based Pentylenediamine Sales Market Share Forecast by Application (2024-2029)
Figure 90. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Application (2024-2029)
